They didn't ban it because it works
Long-term perspective separates people who succeed with the switch from those who abandon treatment
Diabetes Obes Metab 26(6):22092228 Ansari HUH, Qazi SU, Sajid F, Altaf Z, Ghazanfar S, Naveed N et al (2024) Efficacy and safety of Glucagon-Like Peptide-1 receptor agonists on Body Weight and Cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and Meta-analysis
Gene expression and Western blot analysis Total RNA was prepared from cells or tissue and reverse-transcribed
Heat exposure can compromise medication efficacy without obvious visual changes, potentially leading to poor glycemic control or inadequate weight management
As a result, MASLD also poses challenges to financial health care systems 6